BTAI
Price
$1.93
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
11.69M
NRXS
Price
$2.58
Change
+$0.17 (+7.05%)
Updated
Jul 3 closing price
Capitalization
24.58M
74 days until earnings call
Interact to see
Advertisement

BTAI vs NRXS

Header iconBTAI vs NRXS Comparison
Open Charts BTAI vs NRXSBanner chart's image
BioXcel Therapeutics
Price$1.93
Change-$0.00 (-0.00%)
Volume$78.65K
Capitalization11.69M
Neuraxis
Price$2.58
Change+$0.17 (+7.05%)
Volume$134.06K
Capitalization24.58M
BTAI vs NRXS Comparison Chart in %
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. NRXS commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Buy and NRXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BTAI: $1.93 vs. NRXS: $2.58)
Brand notoriety: BTAI and NRXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 25% vs. NRXS: 6%
Market capitalization -- BTAI: $11.69M vs. NRXS: $24.58M
BTAI [@Biotechnology] is valued at $11.69M. NRXS’s [@Biotechnology] market capitalization is $24.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both BTAI and NRXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 6 TA indicator(s) are bullish while NRXS’s TA Score has 6 bullish TA indicator(s).

  • BTAI’s TA Score: 6 bullish, 4 bearish.
  • NRXS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NRXS is a better buy in the short-term than BTAI.

Price Growth

BTAI (@Biotechnology) experienced а -4.93% price change this week, while NRXS (@Biotechnology) price change was +2.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

NRXS is expected to report earnings on Sep 18, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXS($24.6M) has a higher market cap than BTAI($11.7M). NRXS YTD gains are higher at: 9.787 vs. BTAI (-67.739). NRXS has higher annual earnings (EBITDA): -8.11M vs. BTAI (-24.24M). BTAI has more cash in the bank: 31M vs. NRXS (2.01M). NRXS has less debt than BTAI: NRXS (389K) vs BTAI (106M). NRXS has higher revenues than BTAI: NRXS (2.94M) vs BTAI (1.85M).
BTAINRXSBTAI / NRXS
Capitalization11.7M24.6M48%
EBITDA-24.24M-8.11M299%
Gain YTD-67.7399.787-692%
P/E RatioN/AN/A-
Revenue1.85M2.94M63%
Total Cash31M2.01M1,546%
Total Debt106M389K27,249%
FUNDAMENTALS RATINGS
BTAI: Fundamental Ratings
BTAI
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BTAINRXS
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 27 days ago
80%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 7 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUPV10.750.12
+1.13%
Grupo Supervielle SA
ADNT22.380.20
+0.90%
Adient plc
EQ0.32N/A
+0.78%
Equillium
WLK81.11-0.74
-0.90%
Westlake Corp
SGMO0.53-0.01
-1.51%
Sangamo Therapeutics

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with TENX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
N/A
TENX - BTAI
37%
Loosely correlated
+1.22%
SYBX - BTAI
37%
Loosely correlated
-1.67%
CRSP - BTAI
33%
Loosely correlated
+0.97%
SBHMY - BTAI
32%
Poorly correlated
N/A
RXRX - BTAI
31%
Poorly correlated
+1.15%
More

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+7.05%
CVM - NRXS
59%
Loosely correlated
-1.19%
BTAI - NRXS
27%
Poorly correlated
N/A
CTMX - NRXS
25%
Poorly correlated
+0.81%
MRVI - NRXS
24%
Poorly correlated
+0.75%
INBX - NRXS
23%
Poorly correlated
+3.75%
More